AGER and nephritis: On the other hand, active SLE patients had decreased plasma sRAGE levels negatively correlated with disease activity, substantiating the findings that treatment with sRAGE significantly improved nephritis and histologic renal damage in lupus-prone (NZB/NZW) mice [45].